IDEAS home Printed from https://ideas.repec.org/a/cwf/shpart/shp202353.html

Refractory epilepsy and medicinal cannabis: therapeutic advances in Argentina

Author

Listed:
  • Curti, Micaela

Abstract

During the period 2022-2024, the use of cannabidiol (CBD) was evaluated in Argentina as an alternative treatment for refractory epilepsy, a chronic neurological condition characterized by seizures that do not respond to conventional drugs. Refractory epilepsy had a negative impact on the quality of life of patients, which motivated the search for more effective therapies. In this context, CBD, a non-psychoactive compound derived from cannabis, was studied for its potential anticonvulsant effect.The clinical research reviewed showed that CBD significantly reduced seizure frequency in a relevant percentage of patients, especially those with severe syndromes such as Dravet and Lennox-Gastaut. In addition, an acceptable safety profile was reported, with mostly mild adverse effects. In Argentina, the progressive legalization of medical cannabis, through Decree 883/2020 and Law 27,669, allowed progress in the research, production and access to CBD. Through REPROCANN, patients accessed therapeutic formulations under medical supervision.However, structural challenges persisted, such as low national production, high costs, lack of professional training and disparities in access between regions. The review concluded that CBD is a valid therapeutic option for refractory epilepsy, but its implementation requires comprehensive policies that guarantee equitable access, medical training and sustainable national productionr.

Suggested Citation

  • Curti, Micaela, 2025. "Refractory epilepsy and medicinal cannabis: therapeutic advances in Argentina," SAP Health and Policy, South American Publishing.
    • Handle: RePEc:cwf:shpart:shp202353
    DOI: 10.56294/shp202353
    as

    Download full text from publisher

    File URL: https://southam.pub/journals/files/shp/shp202353en.pdf
    Download Restriction: no
    File URL: https://southam.pub/journals/files/shp/shp202353es.pdf
    Download Restriction: no
    File URL: https://libkey.io/10.56294/shp202353?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:cwf:shpart:shp202353. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: South American Publishing Journals Manager (email available below). General contact details of provider: https://southam.pub/journals/shp.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.